10% Owner of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP), Euclidean Capital Llc, sells 21,977 shares worth $742,823
According to PMV Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 15 06:58 PM, company 10% Owner, Euclidean Capital Llc disclosed selling 21,977 shares at a cost of $33.80. At the time of this transaction (Jun 11), this trade was worth $742,823 in total. As of Jun 11, Euclidean Capital Llc now owns 128,359 shares in total worth about $4,407,848.0600000005.
For the last few recent trades made by PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) 10% Owner, Euclidean Capital Llc, we have the following information:
- SEC Form 4 filing: Jun 14: Sold 44,419 shares at the rate of $34.11 per share. Total worth of this trade was $1,515,132. Total number of shares owned as of Jun 14 were 127,099
- SEC Form 4 filing: Jun 09: Sold 39,638 shares at the rate of $33.64 per share. Total worth of this trade was $1,333,422. Total number of shares owned as of Jun 09 were 129,565
- SEC Form 4 filing: Jun 10: Sold 20,633 shares at the rate of $32.68 per share. Total worth of this trade was $674,286. Total number of shares owned as of Jun 10 were 129,980
Posted by
George Daniels
on Wednesday June 16 2021, 11:12 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
